TFS Collaboration with Lobsor Pharmaceuticals AB, on the Development of Lecigon®, Has Resulted in Marketing Authorization of ...
Lund, Sweden, October 08, 2018 / B3C newswire / -- TFS International is thrilled with the announcement that Lecigon®, a new therapeutic system for symptomatic treatment of Advanced Parkinson’s Disease (APD), has been granted marketing authorization in …